continuing resolution

Dear Research Advocate, As anti-vaccine and anti-science rhetoric grows stronger and more toxic, it’s important not to shrink from stepping up to the threat it poses. As Dr. Peter Hotez observed in a powerful editorial last week (well worth the read, for many reasons), “Our scientific training did not include instructions for public engagement or navigating communications in a complex web of disinformation coming from multiple sources.” Dr. Hotez doesn’t let the science community off the hook on communicating though, saying: “we have the knowledge, intellectual heft, and humanitarian obligation” to develop effective ways to communicate science. He gives suggestions on how to meet the moment...
Dear Research Advocate, No one nation now leads the world in all aspects of science and engineering. This point was emphasized today by Julia Phillips, PhD, Chair of the NSB Committee on National Science and Engineering Policy, in a presentation on The State of U.S. Science and Engineering 2022 report. Dr. Phillips underscored how competitiveness going forward relies on making several strategic decisions, including investing much more in fostering underserved talent, and doing more to develop critical and emerging technologies. Catching my eye in the report itself were the lagging indicators on U.S. STEM education; a welcome new broader definition of the STEM workforce; and the dramatic...
Dear Research Advocate, We seldom open this letter highlighting one of our alliance meetings, but yesterday’s discussion about the Omicron variant of COVID-19 is a timely and important exception. We spoke with Amira Roess, PhD, MPH, Professor of Global Health and Epidemiology at George Mason University. She shared information in a way that makes it useful for kitchen table conversations as we all consider how to live and plan given Omicron. One thing that came through clearly in hearing from Dr. Roess is how important fast- and faster-paced research truly is. And the pace of research progress depends on investment. S&T Need & Opportunity: The Hill has published an op-ed I authored...
Dear Research Advocate, It’s tempting to feel overwhelmed and/or helpless in the new year given headlines of disease, dysfunction, and discord. But even as Omicron exacts a toll and Congress struggles for consensus, it is critical to keep in mind that more unites than divides us. In the words of Dr. Francis Collins in an NPR interview last month, “Medical research should never be partisan... You want to find answers to medical problems that are threatening yourself or your family or your community or your constituents. We’re all in this together, wanting solutions to what ails us. To overcome health threats that affect us all, we must stay united in common cause to raise the priority of...
Dear Research Advocate, Welcome to our last letter of 2021. It's been a packed year; one marked by continued challenges along with strong doses of progress and opportunity. Washington is slowing down; it’s a time to gather our strength to face the year ahead with boldness and vigor. The House and Senate adjourned for the year without enacting Build Back Better legislation or completing this year’s appropriations. We ask you to join us as we continue to urge Congress to pass FY22 appropriations as soon as possible. Today is day 83 of operating under an outdated budget. Every day without a new budget stymies lifesaving medical and public health progress. Progress, Challenges: Even while we...
Dear Research Advocate, A year ago this week, the first COVID-19 vaccine was administered in the U.S. (outside of a clinical trial). Tragically, more than 800,000 individuals have died of COVID-19 in the U.S. alone, but an estimated 1.1 million lives in the U.S. have been saved because of the accelerated vaccination effort. The unprecedented feat of developing a vaccine in less than 12 months demonstrates the incredible power of research coupled with public health rigor and vigilance. We need more of both, without delay. Just the Facts: In pandemic response, the knowledge gained from real-time public health response and ongoing research (when that knowledge isn’t exploited for political or...
Dear Research Advocate, “Medical research should never be partisan. It should never get caught up in culture wars or tribal disagreements,” said Francis Collins, MD, PhD, in an interview this week. As Dr. Collins prepares to complete his tenure as NIH Director, he’s sharing lessons learned and advice for the future on issues including science communication and health inequities. There’s another important conversation with Dr. Collins in JAMA. We are deeply honored that Dr. Collins will join us at our 2022 Advocacy Awards program on March 16 to receive the John Edward Porter Legacy Award, generously supported by Ann Lurie . It was announced today that Lawrence A. Tabak, DDS, PhD, a highly...
Dear Research Advocate, The emergence of the Omicron variant underscores the urgency of R&D funding, not only to assure the success of the fight against the constantly evolving SARS-Cov-2, but to prepare for the next pandemic and vanquish other health threats. In an essay in The New York Times , Ashish Jha, MD, MPH, Dean of the School of Public Health at Brown University, speaks to the importance of acting swiftly, not giving in to fear or indifference, and utilizing the tools we have built over the past few years. (Dr. Jha will be joining us for a special discussion on Monday; details below.) But it’s difficult to act swiftly when passage of FY22 funding is still on hold. On the Hill:...
Dear Research Advocate, While Congress is in recess for the Thanksgiving holiday, our (grateful) advocacy doesn’t stop. This week Research!America sent a letter to the Chairs and Ranking Members of the House and Senate Appropriations Committees thanking them for their continued efforts to complete FY22 appropriations and urging them to finalize those funding levels before the December 3 continuing resolution deadline expires. Take a moment now to tweet those same Members of Congress , expressing thanks while encouraging them to pass FY22 appropriations legislation as quickly as possible! Reporting on Public Health Thank You Day 2021: Yesterday, Research!America led the 16th annual...
Dear Research Advocate, Our nation has already been operating for 48 days under a Continuing Resolution (CR) that flat-funds the government at FY21 levels — that’s 48 days too long. The current CR expires on December 3, only six legislative days away. We are hearing increasing concern on Capitol Hill that a full-year CR may be put into place. Under this drastic scenario, billions of dollars in expected, urgently needed FY22 research investment would evaporate. This isn’t a drill, it’s the real thing . We must increase the volume now for completing the FY22 appropriations process. Use our new graphic on your social media channels; Tweet Congressional leaders; email or call ( House | Senate...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient